ColoRectal Cancer in India: catastrOphiC expenDIture and Referral Pathways infLuencE on Presentation and Treatment
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 主要终点
- Catastrophic Expenditure at 6 months
研究概览
简要总结
Observational study to assess barriers for colorectal cancer treatment compliance in India, including quantitative assessment of catastrophic expenditure incidence and qualitative assessment of financial and non-financial barriers.
详细描述
Objective: To identify a vulnerable group of colorectal cancer patients in India who cannot afford or are unable to comply with a treatment plan for colorectal cancer.
Aims:
- To identify the proportion of CRC patients suffering catastrophic expenditure due to out-of-pocket payments for cancer treatment.
- To determine the proportion of patients who are unable to comply with the treatment plan for CRC, at 6 weeks, 3 months and 6 months after diagnosis.
- To identify barriers and solutions to CRC treatment compliance. Design: A mixed-methods study comprising quantitative pilot data from 3 tertiary cancer centres and qualitative work from interviews with patients and healthcare professionals.
Participants: Patients diagnosed with primary colorectal cancer.
Outcomes:
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Catastrophic Expenditure at 6 months
时间窗: 6 months after treatment decision
Catastrophic expenditure (CE) will be defined as out of pocket payments for CRC treatment greater than 40% of patient income (assessed by an in-person questionnaire led by a researcher).
次要结局
- Identification of the main drivers of treatment cost(6 months after treatment decision)
- Colorectal cancer stage at the time of diagnosis(At the time of colorectal cancer diagnosis (coincident with timing of patient enrolment in the study))
- Catastrophic Expenditure at 6 weeks(6 weeks after treatment decision)
- Catastrophic Expenditure at 3 months(3 months after treatment decision)
- Treatment compliance at 6 weeks(6 weeks after treatment decision)
- Treatment compliance at 3 months(3 months after treatment decision)
- Treatment compliance at 6 months(6 months after treatment decision)
